Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug, Supplement Industries Need Formal But Timely Guidance - Stakeholders

This article was originally published in The Tan Sheet

Executive Summary

Food and drug industry stakeholders suggest FDA clarify regulatory expectations and justify requirements through written and finalized formal guidance rather than through speeches and other informal communications
Advertisement

Related Content

Information Disclosure Issues Challenge FDA Transparency Task Force
Information Disclosure Issues Challenge FDA Transparency Task Force
Final AER Guidance Requires Full Address, Recommends Prefatory Language
Final AER Guidance Requires Full Address, Recommends Prefatory Language
Final Guidance For Reporting Adverse Events Gets Serious On Definitions
Supplement Industry Wants Answers From FDA Transparency Task Force
Supplement Industry Wants Answers From FDA Transparency Task Force
Internet Promotions Must Be Redesigned After FDA Cites Sponsored Web Links
NDI Notification Guidance To Assist Puzzled Industry Could Emerge In 2009
Supplement GMPs Leave Vendor Qualification Specs In Manufacturers’ Hands
Advertisement
UsernamePublicRestriction

Register

PS103227

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel